Last week, 571 therapeutics founders and investors joined SOSV’s virtual matchmaking event, generating over 1,000 meetings during the week. A few patterns stood out. Strong...
Incremental biology is giving way to nanobiology—an era where we engineer life at the molecular scale. Today, the frontiers of human health look less like...
At SOSV, we know there’s an eager audience for smart conversations with the best deep tech founders, technologists and investors. We programmed the SOSV Climate...
Announcing the 2026 VC-Founder Therapeutics Matchup, with meetings taking place online between July 13th (Monday) and July 17th (Friday). This virtual event will bring together...
Last June, we announced SOSV’s latest deep tech expansion, the HAX Plasma Forge, a program launchpad dedicated to founders turning breakthroughs in plasma science into...
AI is rapidly reshaping the way venture firms operate — from sourcing and diligence to portfolio support, internal knowledge systems, decision-making, and more. But beyond...
It’s a popular concern that conventional “share-holder primacy” governance is catastrophic for stewarding AI labs and LLMs. OpenAI, Anthropic, Google, Meta, Cohere, and Palantir have all established...
On this sweltering West Texas afternoon, you’re looking for genes that will give future generations of cotton plants a better chance of surviving this hot,...
For decades, Moore’s Law was the semiconductor industry’s north star — predictable, reliable, unstoppable. Now, transistors have hit their physical limits, and the entire industry...
SOSV portfolio company Prolific Machines recently spoke to FiercePharma following a big milestorne for its photomolecular platform, which uses light and optogenetics to “directly and...